Manufacturer record
Modern Laboratories 45-47: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Modern Laboratories 45-47 (Madhya Pradesh) were declared Not of Standard Quality between May 2020 and February 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: VBT 2468, Vitamin B Complex Tablets N.F.I (exp Apr 2026). DTL Thiruvananthapuram (state lab) found it not of standard quality: The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to. Listed in the February 2025 alert.
Records by type
6 records linked to Modern Laboratories 45-47 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Vitamin B Complex Tablets N.F.I | Batch VBT 2468Mfg May 2024 · Exp Apr 2026 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | Batch VBT 2415Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | Batch VBT 2417Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | Batch VBT 2414Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | Batch VBT241 6Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Metoclopramide Hydrochloride Injection IP 5 mg/ml | Batch MEI1902Mfg May 2019 · Exp Apr 2021 | pHpH | RDTL ChandigarhCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.